دورية أكاديمية

GalNAc-T15 in gastric adenocarcinoma: Characterization according to tissue architecture and cellular location.

التفاصيل البيبلوغرافية
العنوان: GalNAc-T15 in gastric adenocarcinoma: Characterization according to tissue architecture and cellular location.
المؤلفون: De Souza Albuquerque MS; Universidade Federal de Pernambuco. marioalbuquerque91@gmail.com., Da Silva-Filho AF, Ferraz Cordeiro M, Deodato de Souza MF, Quirino MWL, Amorim Lima LR, Da Rocha Pitta MG, Martins MR, De Melo Rêgo MJB
المصدر: European journal of histochemistry : EJH [Eur J Histochem] 2018 Jun 14; Vol. 62 (2), pp. 2931. Date of Electronic Publication: 2018 Jun 14.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: PagePress Publications Country of Publication: Italy NLM ID: 9207930 Publication Model: Electronic Cited Medium: Internet ISSN: 2038-8306 (Electronic) Linking ISSN: 1121760X NLM ISO Abbreviation: Eur J Histochem Subsets: MEDLINE
أسماء مطبوعة: Publication: Jan. 2010- : Pavia : PagePress Publications
Original Publication: Pavia : Luigi Ponzio, [1992-
مواضيع طبية MeSH: Adenocarcinoma/*enzymology , Adenocarcinoma/*pathology , Immunohistochemistry/*methods , N-Acetylgalactosaminyltransferases/*metabolism , Stomach Neoplasms/*enzymology , Stomach Neoplasms/*pathology, Adenocarcinoma/surgery ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Female ; Gastrectomy ; Humans ; Male ; Middle Aged ; Prognosis ; Stomach Neoplasms/surgery ; Polypeptide N-acetylgalactosaminyltransferase
مستخلص: Gastric cancer (GC) is the second most common cause of cancer-related deaths in the world. This study aims to investigate the differential tissue expression of ppGalNAc-T15 and to evaluate its possible association with clinical-pathological parameters and outcome of gastric adenocarcinoma patients. For these 70 patients were evaluated the expression by immunohistochemistry to ppGalNAc-T15. Our results showed that 33 (47.1%) patients were ppGalNAC-T15+ positive and 37 (52.9%) negative. Positive staining for ppGalNAc-T15 was significantly present in patients older than 60 years (P=0.0306) and submitted to total gastrectomy (P=0.0087). Also, some results remained at the limit of significance as surgical standing (P=0.0562) and histological grade (P=0.0549). Therefore, the ppGalNAc-T15 immunoreactivity can be useful to understand the prognosis of patients with gastric cancer.
References: World J Gastroenterol. 2014 Feb 21;20(7):1667-80. (PMID: 24587646)
J Gastroenterol Hepatol. 2010 Mar;25(3):512-8. (PMID: 20370729)
Cell Physiol Biochem. 2017;41(5):1801-1829. (PMID: 28376491)
Oncotarget. 2016 Mar 8;7(10):11251-62. (PMID: 26848976)
Proteomics Clin Appl. 2013 Oct;7(9-10):618-31. (PMID: 23857728)
Cancer. 2002 Apr 1;94(7):1939-46. (PMID: 11932895)
Cancer Res. 2008 Sep 15;68(18):7313-22. (PMID: 18794118)
FEBS Lett. 2004 May 21;566(1-3):17-24. (PMID: 15147861)
Cancer Biol Ther. 2009 Apr;8(7):6-15. (PMID: 19417560)
Glycobiology. 2012 Jun;22(6):736-56. (PMID: 22183981)
Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):700-13. (PMID: 24618998)
J Cell Biol. 2010 May 31;189(5):843-58. (PMID: 20498016)
EMBO Rep. 2006 Jun;7(6):599-604. (PMID: 16741504)
Cancer Manag Res. 2018 Feb 07;10:239-248. (PMID: 29445300)
Biomolecules. 2016 Jul 11;6(3):. (PMID: 27409642)
Cancer. 1993 Dec 15;72(12):3641-7. (PMID: 8252480)
Cancer. 1990 Nov 1;66(9):1960-6. (PMID: 2224793)
فهرسة مساهمة: Keywords: Gastric adenocarcinoma; clinical-pathological analyses; immunohistochemistry.; polypeptide N-acetylgalactosaminyltransferases
المشرفين على المادة: EC 2.4.1.- (N-Acetylgalactosaminyltransferases)
تواريخ الأحداث: Date Created: 20180627 Date Completed: 20181029 Latest Revision: 20231213
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC6038116
DOI: 10.4081/ejh.2018.2931
PMID: 29943957
قاعدة البيانات: MEDLINE
الوصف
تدمد:2038-8306
DOI:10.4081/ejh.2018.2931